DNM1L and cancer: In conclusion, our study results suggest that TPH104c- and TPH104m-mediated TNBC cell death is independent of apoptosis and regulated by DRP1, and thus, it is possible that these compounds could be used to treat cancer cells that are resistant to apoptosis, although this remains to be determined.